Oportuzumab (Anti-EpCAM / TROP1 / CD326)Oportuzumab (Anti-EpCAM / TROP1 / CD326)
Move your mouse over image or click to enlarge

Oportuzumab (Anti-EpCAM / TROP1 / CD326)

Oportuzumab (Anti-EpCAM / TROP1 / CD326) is a humanized monoclonal antibody targeting EpCAM. It exhibits potential in treatment of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder. MW :145.4 KD.
Cat# Size Price Qty Buy
A2992-1mg*25 1mg*25
£4,152.00
A2992-1mg*5 1mg*5
£1,384.00
A2992-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2992

Related Documents